CD4 and COVID-19: Considering the late stage of PLWH combined with CD4+ T cell depletion (39), based on existing research, we can speculate that effective antiretroviral treatment and COVID-19 vaccination for HIV-infected people are essential for reducing the SARS-CoV-2 infection rate, severity, and mortality in this population (Table 1).